Literature DB >> 14794919

Persistence of antibodies in human subjects injected with pneumococcal polysaccharides.

M HEIDELBERGER, M M DILAPI, M SIEGEL, A W WALTER.   

Abstract

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES; DIPLOCOCCUS PNEUMONIAE

Mesh：

Substances：

Year:  1950        PMID： 14794919

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  16 in total

Review 1.  Pneumococcal and influenza vaccination: current situation and future prospects.

Authors:  F Horwood; J Macfarlane
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  [Newer method of determination and localization of antibodies; with a special reference to the combination of electrophoresis and serologic antibody-determination].

Authors:  F SCHEIFFARTH; G BERG; W FRENGER
Journal:  Klin Wochenschr       Date:  1956-02-01

3.  Quantitative antibody studies in man. III. Antibody response in leukemia and other malignant lymphomata.

Authors:  D L LARSON; L J TOMLINSON
Journal:  J Clin Invest       Date:  1953-04       Impact factor: 14.808

4.  THE FORMATION OF ANTIBODIES IN MAN AFTER INJECTION OF PNEUMOCOCCAL POLYSACCHARIDES.

Authors:  M Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1957-10-15       Impact factor: 11.205

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 6.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 7.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183

Review 8.  Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations.

Authors:  G A Bruyn; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

Review 9.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.

Authors:  E C Beuvery; A B Leussink; R W Van Delft; R H Tiesjema; J Nagel
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.